1Zou Y, Komuro I,Yamazaki T, et al. Cell type -specific Angiotensin Ⅱ- evoked signal transduction pathways:critical roles of Gbctag am - masubunit, Sre family, and Ras in cardiac fibroblasts. Circ Rcs, 1998, 82:337 - 345.
2Mukae S, Aoki S, Itoh S, et al. β - 2 bradykinin receptor gene polymor - phism is associated with angiotensin - related cough. Hypertens, 2000, 36 : 127 - 131.
3Jorma OK, Ken A, Lindstedt, Role for chymase inheart failure AngiotensinⅡ - depedent or - independent mechanisms? Circulation, 2003, 107:2522 - 2524.
5Wang LX,Ldenshi M,Yahim E,et al. Mechanism of the candioprotective effect of inhibition of the renin - Angiotensin system on ischemia reperfusion - induced mycardial injury. Hypertens Res,2001,24 ( 2 ) : 179.
7Doubeni C, Bigelow C, Lessard D, et al. Trends and outcomes associated with angiotensin - converting enzyme inhibitors. The American Journal of Medicine, 2006, 119(7) :616.
8Gaddam V. ACE inhibitors in cardiovascular disease. J Ark Med Soc, 2002,98 (10) :328 -329.
6Kelly DJ, Stein-Oakley A, Zhang Y, et al. Fas-induced apoptosis is a feature of progressive diabetic nephropathy in transgenic (mRen-2) 27 rats: attenuation with renin-angiotensin blockade. Nephrology,2004, 9: 7-13.
7Locatelli F, Canaud B, Eckardt KU, et al.The importance of diabetic nephropathy in current nephrological practice. Nephrol Dial Transplant, 2003, 18: 1716-1725.
8Keane WF, Lyle PA. Recent advances in management of type 2 diabetes and nephropathy: lessons from the RENAAL study. Am J Kidney Dis, 2003, 41 Suppl 1: S22-S25.
9American Diabetes Association. Nephropathy in Diabetes. Diabetes Care, 2004, 27Suppl 1: S79-S83.
10Laverman GD, Remuzzi G, Ruggenenti P.ACE inhibition versus angiotensin receptor blockade: which is better for renal and cardiovascular protection? J Am Soc Nephrol, 2004, 15: S64-S70.
